Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Relmada Therapeutics Inc. (RLMD)

49.99   3.86 (8.37%) 02-20 16:00
Open: 46.49 Pre. Close: 46.13
High: 52.16 Low: 46.16
Volume: 232,559 Market Cap: 734M
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic pain, and/or other potential CNS pathological conditions. The company is also developing LevoCap ER, an extended release, abuse deterrent, and proprietary formulation of the opioid analgesic levorphanol for the treatment of pain; BuTab, a formulation of oral, modified release buprenorphine for chronic pain and opioid dependence; and MepiGel, a proprietary topical dosage form of the local anesthetic mepivacaine for the treatment of painful peripheral neuropathies, such as painful diabetic neuropathy, postherpetic neuralgia, and painful HIV-associated neuropathy. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.191 - 52.346 52.346 - 52.518
Low: 45.734 - 45.905 45.905 - 46.097
Close: 49.667 - 49.943 49.943 - 50.253

Technical analysis

as of: 2020-02-20 4:43:20 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 60.92     One year: 71.16
Support: Support1: 42.91    Support2: 37.19
Resistance: Resistance1: 52.16    Resistance2: 60.92
Pivot: 43.61
Moving Average: MA(5): 45.89     MA(20): 43.79
MA(100): 32.49     MA(250): 14.92
MACD: MACD(12,26): 1.64     Signal(9): 1.21
Stochastic oscillator: %K(14,3): 80.74     %D(3): 75.32
RSI: RSI(14): 71.08
52-week: High: 52.16  Low: 1.57  Change(%): 843.2
Average Vol(K): 3-Month: 16942  10-Days: 9058

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
RLMD has closed above the upper band by 13.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 21.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer
NEW YORK, Jan. 10, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Maged Shenouda has been appointed the Company's new Chief Financial…

Relmada Therapeutics Strengthens Board of Directors with Appointments of Life Sciences Industry Veterans, Eric Schmidt, Ph.D., and John Glasspool
NEW YORK, Dec. 20, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointments of life sciences industry veterans, Eric Schmidt, Ph.D., and…

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Shares Out. (M) 14.67
Shares Float (M) 7.86
% Held by Insiders 10.64
% Held by Institutions 16.18
Shares Short (K) 468
Shares Short P. Month (K)

Stock Financials

EPS -2.210
Book Value (p.s.) 0.600
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -158.6
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.870
Qtrly Earnings Growth
Operating Cash Flow (M) -11.36
Levered Free Cash Flow (M) -10.79

Stock Valuations

P/E -22.62
P/E Growth Ratio 0.08
P/BV 83.32
P/CF -64.56

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-09-29
Last Split Ratio 0.25
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.